Logos Global Management LP - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 87 filers reported holding DICE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 1.2%.

Quarter-by-quarter ownership
Logos Global Management LP ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$11,746,500
-43.0%
410,000
-37.9%
1.68%
-30.3%
Q4 2022$20,592,000
-6.4%
660,000
-39.2%
2.41%
-10.9%
Q3 2022$22,009,000
+43.9%
1,085,251
+10.1%
2.71%
-3.5%
Q2 2022$15,291,000
-42.3%
985,251
-28.9%
2.80%
-18.4%
Q1 2022$26,500,000
-37.1%
1,385,251
-16.8%
3.44%
-20.9%
Q4 2021$42,122,000
+10.9%
1,664,251
+43.4%
4.34%
+58.5%
Q3 2021$37,998,0001,160,2512.74%
Other shareholders
DICE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders